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E-mail address: n.m.hulsman@rev.umcg.nl (N.M. HThe diagnosis Complex Regional Pain Syndrome type I (CRPS-I) is based on clinical symptoms, including
motor symptoms. Histological changes in muscle tissue may be present in the chronic phase of CRPS-I.
Aim of this study was to analyze skeletal muscle tissue from amputated limbs of patients with CRPS-I,
in order to gain more insight in factors that may play a role in changes in muscles in CRPS-I. These
changes may be helpful in clarifying the pathophysiology of CRPS-I. Fourteen patients with therapy resis-
tant and longstanding CRPS-I, underwent an amputation of the affected limb. In all patients histological
analysis showed extensive changes in muscle tissue, such as fatty degeneration, ﬁbre atrophy and nuclear
clumping, which was not related to duration of CRPS-I prior to amputation. In all muscles affected, both
type 1 and type 2 ﬁbre atrophy was found, without selective type 2 ﬁbre atrophy. In four patients, type
grouping was observed, indicating a sequence of denervation and reinnervation of muscle tissue. In two
patients even large group atrophy was present, suggesting new denervation after reinnervation. Compar-
ison between subgroups in arms and legs showed no difference in the number of changes in muscle tis-
sue. Intrinsic and extrinsic muscles were affected equally. Our ﬁndings show that in the chronic phase of
CRPS-I extensive changes can be seen in muscle tissue, not related to duration of CRPS-I symptoms. Signs
of neurogenic myopathy were present in ﬁve patients.
 2008 European Federation of Chapters of the International Association for the Study of Pain. Published
by Elsevier Ltd. All rights reserved.1. Introduction
The term Complex Regional Pain Syndrome type I (CRPS-I), to
describe a syndrome previously known under the name of Reﬂex
Sympathetic Dystrophy, was recommended in 1994 by the Interna-
tional Association for the Study of Pain (IASP) (Merskey and
Bogduk, 1994; Stanton-Hicks et al., 1995). The term is based on
clinical symptoms including sympathetic, somatomotor and
somatosensory symptoms. The pathophysiology of CRPS-I is still
basically unknown, although peripheral, autonomic and central
mechanisms are likely involved (Raja and Grabow, 2002; Jänig
and Baron, 2003). To facilitate clinical research and permit speciﬁc
targeting of treatments, two subtypes of CRPS have been suggested
by the IASP (Merskey and Bogduk, 1994; Stanton-Hicks et al.,
1995). CRPS type I may develop after trauma without nerve lesion,
type II develops after trauma with nerve lesion. Up till now, the
description of subtypes has as yet not been helpful in clarifying
pathophysiology or targeting treatment.apters of the International Associa
+31 50 3611708.
ulsman).Inmanypatientswith CRPS-Imotor symptoms are found, such as
muscle weakness, muscle atrophy and reduced range of motion
(Veldman et al., 1993; Raja and Grabow, 2002; Jänig and Baron,
2003). Furthermore, pain and a neglect-like syndrome may lead to
disuse of the limb with even more disabling consequences (Galer
and Jensen, 1999). Observing the motor symptoms in chronic
CRPS-I, changes inmuscle tissuemay be expected. Reports on histo-
logical analysis of skeletal muscle tissue in CRPS-I are scarce for two
reasons. Biopsies to obtain tissue from an affected limb are often
painful and a widespread belief exists that biopsies may deteriorate
clinical symptoms of CRPS-I. Therefore histological analysis of tis-
sues fromamputated limbs ispreferred. Studies onhistological anal-
ysis of tissue in CRPS-I show results varying from myopathy and
microangiopathy in muscle tissue (Tilman et al., 1990; van der Laan
et al., 1998) to neuropathologic changes in skin tissue (Albrecht
et al., 2006; Oaklander etal., 2006). These study results indicate that
further histopathological investigation of amputated limbs may be
helpful in clarifying the pathophysiology of CRPS-I.
Based on metabolic properties, skeletal muscle ﬁbres can be dis-
tinguished in: Type 1/slow oxidative/red, Type 2A/fast oxidative/
red, Type 2B/fast glycolytic/white and Type 2C/undifferentiated.tion for the Study of Pain. Published by Elsevier Ltd. All rights reserved.
Fig. 1. (1A), (1B), (1C), (1D) Scheme of denervation patterns. (1A) Normal
checkerboard pattern of type 1 (brown) and type 2 ﬁbres (pink). (1B) Denervation,
showing atrophy of both type 1 and type 2 ﬁbres. (1C) Reinnervation showing type
grouping of muscle ﬁbres. (1D) New denervation, showing large group atrophy.
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different skeletal muscle ﬁbres can be evaluated under the micro-
scope. An ATP-ase staining at pH 4.3 will result in dark Type 1 and
light Type 2A and 2B ﬁbres. All muscle ﬁbres in a speciﬁc motor
unit are of the same metabolic type (Dubowitz and Pearse,
1960). Disuse causes a decrease in size of muscle ﬁbres (atrophy),
which affects type 2 ﬁbres more than type 1 ﬁbres (Dubowitz et al.,
2007). Muscle ﬁbres will also atrophy when deprived of the trophic
inﬂuence of their nerve (denervation), which affects both type 1
and type 2 ﬁbres (Fig. 1A and B). Reinnervation of muscle tissue
leads to so-called type grouping (Fig. 1C), indicating that small
muscle ﬁbres and large muscle ﬁbres tend to cluster. If denervation
occurs again, large group atrophy may be observed (Dubowitz et
al., 2007) (Fig. 1D). These typical atrophy patterns can be used in
studying the pathophysiology of chronic CRPS-I myopathy.
Aim of this study was to analyze skeletal muscle tissue from
amputated limbs of patients with chronic CRPS-I, in order to get




Patients with CRPS-I of a limb with serious infections in that
limb, a complete afunctional limb and requesting an amputationof the affected limb were referred to the Centre for Rehabilitation
of the University Medical Centre Groningen. CRPS-I was diagnosed
in all patients according to IASP criteria (Merskey and Bogduk,
1994). In the period of May 2000 to June 2005 14 patients under-
went amputation of one limb.
Medical history was retrieved from the medical records. The fol-
lowing data were collected: gender, co-morbidity, affected limb,
inciting event, indication for amputation, CRPS-I duration at ampu-
tation, level of amputation, age at amputation and follow-up data
about recurrence of CRPS-I. Duration of CRPS-I was calculated from
the moment the patients met diagnostic criteria for the ﬁrst time.
Both patients with CRPS-I of the upper and lower extremity were
included. Patients with a medical history of nerve lesions, nerve
disease or diabetes were excluded.2.2. Muscle tissue
Patients were asked for permission to perform histological anal-
ysis of the amputated limb. All patients or their care givers, in case
of children, gave written informed consent prior to amputation. In
6 patients sampling of muscle tissue was performed according to
the written protocol (Appendix A). In 8 patients 3 or more muscle
samples were obtained with at least one intrinsic and one extrinsic
muscle from different innervating nerves.
Muscle tissue was stained for light microscopic investigations;
muscle tissue for parafﬁn embedding and frozen tissue for en-
zyme-histochemistry. ATP-ase staining was performed for ﬁbre
typing. From frozen muscle tissue 5 lm sections were cut and
dried for 30 min followed by pre-incubation with a Veronal-Ace-
tate/HCl buffer at pH 4.3 for 5 min. Thereafter incubation was
performed with the same buffer containing 30 mg of ATP at
37 C for 45 min. Thereafter a series of rinsing steps were per-
formed (1% CaCl2–Formol 2  5 min, 2% Kobaltchloride 3 min,
aqua-dest 1 min, 2% Sodiumsulﬁde for 10 s and again aqua-dest),
followed by a counterstaining with eosin. This enzyme-histo-
chemical staining procedure resulted in dark-brown type 1 ﬁbres,
pink type 2A and 2B ﬁbres and light brown 2C (undifferentiated)
ﬁbres.
The enzyme-histochemical stainings of the muscle tissue were
evaluated for the presence of type grouping, indicating a sequence
of denervation and reinnervation of the muscle tissue. Further-
more, the distribution of atrophy amongst the various ﬁbre types
was evaluated. Selective atrophy of type 2 ﬁbres would point more
in the direction of disuse, whereas a combined atrophy of type 1
and 2 ﬁbres would point more in the direction of a neurogenic
myopathy (Fig. 1A–D).
Tissue characteristics assessed were: fatty degeneration, con-
nective tissue formation, ﬁbre atrophy, ﬁbre diameter variance, nu-
clear clumping and large group atrophy (Fig. 2A–C). In healthy
muscle tissue these characteristics are not present. Classiﬁcation
of severity of tissue changes was self-designed, as no validated
classiﬁcation is available in the literature. The following classiﬁca-
tion was made: fatty degeneration was ranked into: 0 = absent;
1 = present, connective tissue formation into: 0 = absent; 1 = pres-
ent, ﬁbre diameter variance into: 0=none; 1 = little; 2 = intermedi-
ate; 3 = severe, ﬁbre atrophy into: 0 = none; 1 = focal; 2 = diffuse,
nuclear clumping into: 0 = none; 1 = focal; 2 = diffuse and large
group atrophy into 0 = absent; 1 = present. Large group atrophy
indicates to a sequence of denervation, reinnervation and again
denervation, as earlier described in the introduction.
All specimens were reviewed by the last author. The last author
is a neuropathologist and was blinded to the clinical history. The
ﬁrst author was present in the same session to process the ﬁndings.
A selection of the samples was reviewed a second time by both
authors, obtaining the same results.
Fig. 2. (2A), (2B), (2C) Photomicrographs of transverse sections of various skeletal muscle samples, ranging from minimally to severely affected. The bars in the ﬁgures
represent 100 lm. (2A) shows an increase in the variance of the muscle ﬁbre diameter. Relatively atrophic muscle ﬁbres are indicated with an asterisk. (2B) shows clumping
of pyknotic nuclei (arrows) and some ﬁbrosis (asterisks) pointing at more chronic atrophy. (2C) shows diffuse atrophy with nuclear clumping and fatty changes (asterisks).
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Descriptive data analysis of tissue characteristics was conducted
using SPSS for Windows version 14. Different tissue changes were
dichotomized for each sample into absent or present. Per sample
the number of tissue changes was summed into the total number
of tissue changes present. Duration of CRPS-I was correlated with
the total number of tissue changes to analyze a possible relation-
ship between duration of CRPS-I and the total number of tissue
changes in the samples. Additionally nonparametric tests (Mann–
Whitney U) were used to analyze differences in total number of tis-
sue changes between samples from arms and legs and between
samples from intrinsic and extrinsic muscles.
3. Results
3.1. Patients
The group of patients consisted of 2 males and 12 females, with
a median age at amputation of 39.5 years (IQR 29.5; 47.2), and
median duration of CRPS-I of 4.5 years (IQR 2.0; 8.0) (Table 1). In
all patients the limb was afunctional for more than 2 years prior
to amputation because of pain, oedema, muscle weakness and re-
duced range of motion. In 11 patients the symptoms of CRPS-I were
preceded by minor trauma or minor surgery. In 3 patients there
was no apparent inciting event. Amputation was performed in 3
arms and 11 legs (Table 1). All patients had received several treat-
ments before amputation, such as physiotherapy, oxygen free rad-
ical scavengers, mannitol infusions and various drugs. Seven
patients were treated with sympathetic nervous blockade or sym-pathectomy (patients 2, 3, 4, 8, 9, 11 and 13) (Table 1). In 2 patients
(patients 8 and 10) more than one limb was affected by CRPS-I
(respectively, 4 and 2 limbs), but only one limb was amputated.
Follow-up data after amputation were present for all patients, with
a median follow-up duration of 16.5 months (IQR 5.6; 39.0). Nei-
ther signs of recurrence of CRPS-I were present in the stumps,
nor signs of a newly developed CRPS-I in another part of the body.
3.2. Muscle tissue
In all amputated limbs changes of skeletal muscle tissue were
observed (Table 2, Figs. 2A–C, and 3A and B). In a total of 55 sam-
ples only 2 samples were normal. These samples were taken from
extrinsic muscles of two different patients. Fatty degeneration was
present in half of the samples, and connective tissue formation in
almost none of the samples. Large group atrophy was present in
4 samples of patient 5 and 14. Patient 5 was female, 16 years of
age, with no apparent inciting event for CRPS-I. The duration of
symptoms till amputation was at least 2 years. Patient 14 was
male, 49 years of age, with CRPS-I after a calcanean tendon rup-
ture; the duration of symptoms till amputation was at least 4
years. In both patients muscle tissue changes were more severe
than in the other patients. In the two patients with more than
one limb affected, tissue changes did not differ in severity from
those of other patients. A longer duration between diagnosis of
CRPS-I and amputation did not signiﬁcantly correlate with the
number of tissue changes in the specimens (q = 0.15, p = 0.26).
The number of tissue changes did not differ between samples from
intrinsic muscles (mean: 3.5; SD: 1.0) and those from extrinsic
muscles (mean: 3.2; SD: 1.3) (p = 0.34). The number of tissue
Table 1





















1 47 F 9 Leg 3 KEA Pain, rROM,
afunctional
None PT, OFRS, VD 39















4 16 F 4 Leg 4 KEA Pain, rROM,
afunctional
Sprained ankle PT, OFRS, VD,
SB, ST
41
5 25 F 2 Leg 3 TFA Pain, ulceration,
afunctional
None PT, OFRS, VD 17







7 48 F 12 Leg 4 TFA Pain, afunctional Arthroscopy knee PT, VD, MI 23
8 32 F 6 Arm 4 THA Pain, ulceration,
afunctional






9 38 F 3 Leg 4 KEA Pain, ulceration,
afunctional
HNP operation PT, OFRS, VD,
MI, SB, ST
39
10 31 F 8 Leg 4 KEA Ulceration,
infections,
afunctional
Minor trauma PT, OFRS, VD,
MI
6
11 36 F 5 Leg 4 TFA Ulceration,
afunctional
Sprained ankle PT, VD, ST 16
12 23 M 2 Arm 4 AF Ulceration Amputation MCP dig III PT, VD, MI 4.5
13 42 F 8 Leg 4 TTA Pain, afunctional Minor trauma PT, OFRS, VD,
MI, SB, ST
13
14 49 M 4 Leg 4 KEA Pain, afunctional Calcanean tendon
rupture
PT, VD 10
F = female, M = male, CRPS-I = complex regional pain syndrome type I, TFA = transfemoral amputation, KEA = exarticulation of the knee, TTA = transtibial amputation,
THA = transhumeral amputation, AF = amputation of forearm, rROM = reduced range of motion, afunctional = afunctional limb, HNP = hernia nuclei pulposi, MCP = meta-
carpophalangeal, dig = digit, PT = physiotherapy OFRS = oxygen free radical scavengers, VD = various drugs, MI = mannitol infusion, SB = sympathetic block,
ST = sympathectomy.
Table 2
Changes in muscle tissue samples of 14 amputated limbs
Category Arms (n of
samples = 13) % (n)
Legs (n of
samples = 42) %
(n)
Extrinsic muscle (n of
samples = 28) % (n)
Intrinsic muscle (n of
samples = 27) % (n)
All (n of
samples = 55) %
(n)
1. Fatty degeneration 0 = absent 38 (5) 50 (21) 50 (14) 44 (12) 47 (26)
1 = present 62 (8) 50 (21) 50 (14) 56 (15) 53 (29)
2. Connective tissue formation 0 = absent 100 (13) 93 (39) 96 (27) 93 (25) 95 (52)
1 = present 0 (0) 7 (3) 4 (1) 7 (2) 5 (3)
3. Fibre diameter variance 0 = none 0 (0) 5 (2) 7 (2) 0 (0) 4 (2)
1 = little 92 (12) 69 (29) 68 (19) 81 (22) 74 (41)
2 = intermediate 8 (1) 21 (9) 21 (6) 15 (4) 18 (10)
3 = severe 0 (0) 5 (2) 4 (1) 4 (1) 4 (2)
4. Fibre atrophy 0 = none 0 (0) 5 (2) 7 (2) 0 (0) 4 (2)
1 = focal 100 (13) 69 (29) 71 (20) 81 (22) 76 (42)
2 = diffuse 0 (0) 26 (11) 21 (6) 19 (5) 20 (11)
5. Nuclear clumping 0 = none 15 (2) 29 (12) 28 (8) 22 (6) 26 (14)
1 = focal 85 (11) 50 (21) 54 (15) 63 (17) 58 (32)
2 = diffuse 0 (0) 21 (9) 18 (5) 15 (4) 16 (9)
6. Large group atrophy 0 = absent 100 (13) 90 (38) 93 (26) 93 (25) 93 (51)
1 = present 0 (0) 10 (4) 7 (2) 7 (2) 7 (4)
Number of categories
containing tissue changes
0 0 (0) 5 (2) 7 (2) 0 (0) 4 (2)
1–2 15 (2) 19 (8) 21 (6) 15 (4) 18 (10)
3–4 85 (11) 64 (27) 64 (18) 74 (20) 69 (38)
5–6 0 (0) 12 (5) 7 (2) 11 (3) 9 (5)
Percentages are column percentages; due to rounding of sum percentages may not equal 100%.
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3.5; SD: 0.8) and those from legs (mean: 3.3; SD: 1.3) (p = 0.64).
Concerning the ATP-ase enzyme-histochemistry, in all the af-
fected muscles described above, both type 1 and type 2 ﬁbres
showed atrophy, without predilection for one or the other. In 4 pa-tients clear signs of type grouping could be observed, indicating a
sequence of denervation and reinnervation (i.e. neuronal damage).
In patients 1, 10 and 14 the type grouping was found in the m.
adductor hallucis. In patient 2 the type grouping was found in both
the m. extensor digitorum and m. ﬂexor digiti minimi.
Fig. 3. (3A) and (3B) Photographs of transverse sections of skeletal muscle samples with enzyme-histochemical staining for evaluation of the presence of type grouping and
the distribution of atrophy amongst type 1 and type 2 ﬁbres. In both ﬁgures atrophy of both type 1 and type 2 ﬁbres is present. The bars represent 500 lm in 3A and 100 lm
in 3B.
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Extensive changes in muscle tissue were present in patients
with longstanding CRPS-I. The changes were similar in all patients.
The investigated muscle tissue belonged to patients with CRPS-I
with an immobilized, afunctional limb for more than 2 years. Prior
to this study, a correlation between duration of CRPS-I and the
number of muscle tissue changes was expected, a result of a longer
period of disuse. However, in the current study no such relation-
ship was found.
CRPS described by the IASP criteria differentiates between two
subtypes, type I and II, according to the presence of nerve lesions
after trauma. In the current study, both type 1 and type 2 ﬁbre atro-
phy was found in all the affected muscles. Would disuse have been
the cause of muscle changes, type 2 ﬁbres would have atrophied
more selectively. In 4 out of 14 patients, type grouping was ob-
served, indicating a sequence of denervation and reinnervation of
muscle tissue. In 2 out of 14 patients even large group atrophy
was present, suggesting new denervation after reinnervation (in
one of these patients type grouping was also present). When nerve
damage plays a role in CRPS-I, onewould also expect to see intrinsic
muscles being more affected than extrinsic muscles and legs being
more affected than arms, because of the difference in nerve length
and nerve vulnerability. Although type grouping occurred more of-
ten in the intrinsic muscle tissue of the foot, no difference in the
number of changes on routine histology was found between sam-
ples from arms and those from legs. In themedical history of the pa-
tient with large group atrophy, neither for the patients with type
grouping nor for the patient with both large group atrophy and type
grouping a nerve lesion was described. According to CRPS-I criteria
there should not be nerve damage present. The initiating events of
CRPS-I in these patients consisted of minor trauma or were not
apparent, without reason for nerve damage. The question then
arises if nerve damage can be seen in samples of nerve tissue and,
if so, what causes this nerve damage since no apparent nerve dam-
age was recorded in the history of these patients. Perhaps, in the
chronic phase of CRPS-I, other factors than the initial inciting event
may cause denervation. All patients received several types of treat-
ment before amputation (Table 1). However, these treatments,
including sympathectomy, are not known for causing motor nerve
damage and therefore considered not relevant to our ﬁndings.
Perhaps the circulation in or to the nerve is hampered by the
chronic existence of oedema or microangiopathy. Additionally
inﬂammation of blood vessels or nerve tissue also may play a role
in denervation observed in the two patients. Trophic changes are
more frequently present in patients with CRPS-I in the chronicphase, compared to patients with CRPS-I in earlier phases (Veld-
man et al., 1993). However, of these patients with chronic CRPS-
I, more than half did not show clinical signs of atrophy (Veldman
et al., 1993). In the current study all patients with longstanding
CRPS-I showed clinical signs of muscle atrophy.
In an histological analysis of muscle tissue of the gastrocnemius
and the soleus muscle of amputated lower limbs in 8 patients be-
cause of CRPS-I, a variety of changes was seen (van der Laan et al.,
1998). In the muscles a decrease of type 1 ﬁbres was found, as well
as an increase of lipofuscin and atrophic ﬁbres. Capillaries showed
microangiopathy similar to the histological abnormalities found in
skeletal muscle of diabetic patients which seem to be related to
ischemic conditions. In an electron microscopical evaluation of
muscle biopsies of gastrocnemius muscle in patients with chronic
CRPS-I both neuropathic and myogenic muscle changes were seen,
with signs for oxidative stress. No signs of cellular inﬂammation
occurred (Tilman et al., 1990).
In the current study 14 patients were included with samples
from different subgroups of muscles. By using several samples we
tried to ﬁnd speciﬁc indications for denervation. Both van der Laan
and Tilman describe changes in cytological architecture, but do not
speciﬁcally describe atrophy patterns that may point to neurogenic
myopathy (Tilman et al., 1990; van der Laan et al., 1998).
A limitation of the study is that we were not able to compare
our tissue samples with healthy tissue samples. In our hospital
limbs may be amputated because of atherosclerotic or neoplastic
changes; the latter mostly after (local) chemotherapy. Tissues from
these limbs may not sufﬁce as controls.
On clinical presentation to our centre all patients had not used
their affected limb for over two years and all presented with con-
tractures and pain. To discern paralysis from disuse solely on clin-
ical presentation was therefore, not possible. Moreover, because of
the heterogeneity of the symptoms of CRPS-I it was very difﬁcult to
get a homogenous population in terms of clinical symptoms. We
therefore chose only to describe clinical symptoms and not to
use them as parameters in relation to the histological ﬁndings.
To be able to compare muscle tissue in this group of patients sam-
pling was performed according to protocol.
Results of nerve conduction studies or EMG prior to amputation
were not used in our study. In half of the patients these studieswere
performed in an earlier stage as an adjuvant method in diagnosis,
however with very heterogeneous methods and results. Moreover,
nerve conduction studies and EMG in CRPS-I are often very painful
and, therefore, difﬁcult to use as a method to assess nerve damage.
Our ﬁndings show that in the chronic phase of CRPS-I extensive
changes are present in muscle tissue, which are not related to the
736 N.M. Hulsman et al. / European Journal of Pain 13 (2009) 731–736duration of CRPS-I. No differences were seen in different subgroups
of muscles (i.e. intrinsic vs. extrinsic; arm vs. leg). The most impor-
tant ﬁnding was that in 5 patients signs of denervation were found
pointing at a nerve lesion. Factors that may play a role in changes
of muscle tissue can be neuropathic or vascular in origin, in which
disuse may be a less important factor, which is underlined by the
absence of selective type 2 ﬁbre atrophy. For the future we are
planning to investigate human nerve tissue and vascular tissue
as a following step to clarify pathophysiology in CRPS-I.
Appendix A
Protocol for obtaining samples of various tissues in amputated
limbs of CRPS-I patientsMethod of sampling
Arm – intrinsic hand muscles: m. adductor pollicis (ulnar nerve), m. abductor
pollicis (median nerve)
– extrinsic hand muscles: m. ﬂexor digitorum superﬁcialis (median
nerve), m. ﬂexor carpi ulnaris (ulnar nerve), m. extensor carpi radialis
(radial nerve)Leg – intrinsic foot muscles: m. adductor hallucis (tibial nerve) m. extensor
digitorum brevis (peroneal nerve)
– extrinsic foot muscles: m. tibialis anterior (peroneal nerve), m. gastroc-
nemius (tibial nerve)Method of investigation
– muscle tissue for parafﬁn embedding and frozen tissue for enzyme-his-
tochemistry (ATP-ase for ﬁbre typing)m. = muscle, ATP = adenotriphosphate.References
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